Literature DB >> 21792581

Update on attention-deficit/hyperactivity disorder and tic disorders: a review of the current literature.

Heather A Simpson1, Leah Jung, Tanya K Murphy.   

Abstract

Tic disorders impact quality of life, but when they are co-occurring with attention-deficit/hyperactivity disorder, the combined impact takes a toll on psychosocial functioning and adds another layer of complexity to treatment approaches. A review of the current literature supports evidence of a unique relationship between comorbid attention-deficit/hyperactivity disorder and tic disorders, emphasizing the intricate phenotype and impairment associated with these co-occurring conditions. The complexity of these symptoms requires careful diagnosis and appropriate treatment as determined by the level of impairment and can include pharmacotherapy, behavioral interventions, or a combination of therapies. To achieve the greatest benefits in improving quality of life and eliminating further comorbidity, an ideal treatment plan would include a comprehensive evaluation as well as a hierarchical treatment approach involving education of the child, family, and teachers; careful medication management; and cognitive and behavioral training.

Entities:  

Mesh:

Year:  2011        PMID: 21792581     DOI: 10.1007/s11920-011-0223-1

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  57 in total

1.  Familiality of Tourette syndrome, obsessive-compulsive disorder, and attention-deficit/hyperactivity disorder: heritability analysis in a large sib-pair sample.

Authors:  Carol A Mathews; Marco A Grados
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-11-18       Impact factor: 8.829

2.  Randomized trial of parent management training in children with tic disorders and disruptive behavior.

Authors:  Lawrence Scahill; Denis G Sukhodolsky; Karen Bearss; Diane Findley; Vanya Hamrin; Deirdre H Carroll; Adrienne L Rains
Journal:  J Child Neurol       Date:  2006-08       Impact factor: 1.987

Review 3.  First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants.

Authors:  Veit Roessner; Monika Robatzek; Guido Knapp; Tobias Banaschewski; Aribert Rothenberger
Journal:  Dev Med Child Neurol       Date:  2006-07       Impact factor: 5.449

4.  Relaxation therapy in Tourette syndrome: a pilot study.

Authors:  A Bergin; H R Waranch; J Brown; K Carson; H S Singer
Journal:  Pediatr Neurol       Date:  1998-02       Impact factor: 3.372

5.  Testing tic suppression: comparing the effects of dexmethylphenidate to no medication in children and adolescents with attention-deficit/hyperactivity disorder and Tourette's disorder.

Authors:  Gholson J Lyon; Stephanie M Samar; Christine Conelea; Marcel R Trujillo; Christina M Lipinski; Christopher C Bauer; Bryan C Brandt; Joshua J Kemp; Zoe E Lawrence; Jonathan Howard; F Xavier Castellanos; Douglas Woods; Barbara J Coffey
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-08       Impact factor: 2.576

6.  The behavioral spectrum of tic disorders: a community-based study.

Authors:  R Kurlan; P G Como; B Miller; D Palumbo; C Deeley; E M Andresen; S Eapen; M P McDermott
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

7.  Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.

Authors:  Michael H Bloch; Kaitlyn E Panza; Angeli Landeros-Weisenberger; James F Leckman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-09       Impact factor: 8.829

8.  Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome.

Authors:  Roger D Freeman
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-06       Impact factor: 4.785

9.  Sleep patterns in children with attention-deficit/hyperactivity disorder, tic disorder, and comorbidity.

Authors:  Roumen Kirov; Joerg Kinkelbur; Tobias Banaschewski; Aribert Rothenberger
Journal:  J Child Psychol Psychiatry       Date:  2007-06       Impact factor: 8.982

10.  European guidelines on managing adverse effects of medication for ADHD.

Authors:  J Graham; T Banaschewski; J Buitelaar; D Coghill; M Danckaerts; R W Dittmann; M Döpfner; R Hamilton; C Hollis; M Holtmann; M Hulpke-Wette; M Lecendreux; E Rosenthal; A Rothenberger; P Santosh; J Sergeant; E Simonoff; E Sonuga-Barke; I C K Wong; A Zuddas; H-C Steinhausen; E Taylor
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-11-03       Impact factor: 4.785

View more
  6 in total

Review 1.  Neurobiology of the Premonitory Urge in Tourette's Syndrome: Pathophysiology and Treatment Implications.

Authors:  Andrea E Cavanna; Kevin J Black; Mark Hallett; Valerie Voon
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2017-01-25       Impact factor: 2.198

2.  Barkley's Parent Training Program, Working Memory Training and their Combination for Children with ADHD: Attention Deficit Hyperactivity Disorder.

Authors:  Zahra Hosainzadeh Maleki; Ali Mashhadi; Atefeh Soltanifar; Fatemeh Moharreri; Ali Ghanaei Ghamanabad
Journal:  Iran J Psychiatry       Date:  2014-04

3.  Tic Disorder of Children Analyzed and Diagnosed by Magnetic Resonance Imaging Features under Convolutional Neural Network.

Authors:  Chunxia Wu; Qingerile Si; Budegerile Su; Lan Mu; Gaowa Bao; Musiguleng Ji; Daohu Ao
Journal:  Contrast Media Mol Imaging       Date:  2021-11-11       Impact factor: 3.161

4.  Assessment and Management of Tic Disorders in Pediatric Primary Care Settings.

Authors:  Mina Yadegar; Sisi Guo; Emily J Ricketts; Samuel H Zinner
Journal:  Curr Dev Disord Rep       Date:  2019-06-07

5.  Tourette syndrome and consciousness of action.

Authors:  Andrea E Cavanna; Andrea Nani
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-09-23

6.  Questioning the long-term stability of the additive model in comorbid CTD+ADHD - The transition from childhood to adulthood.

Authors:  Olga Müller; Aribert Rothenberger; Geza L Brüni; Biyao Wang; Andreas Becker
Journal:  PLoS One       Date:  2018-11-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.